Scholar Rock Chief Scientific Officer Conducts Multiple Sales Throughout January 2026 The Chief Scientific Officer of Scholar Rock Holding Corp has made multiple filings regarding disposals in January 2026, but this should not alarm investors.
3 Questions Investors Should Answer Before Buying Beyond Meat Stock Beyond Meat was a market darling when it first went public, but you'll want to tread cautiously if you are looking to buy it today.
Large Biotech Fund Sells Shares of Cogent Biosciences for Over $120M A large biotech fund that's an insider at Cogent Biosciences recently sold millions of shares amid the company's best annual performance ever in 2025.
Should You Buy Nio Stock While It's Below $5 a Share? Nio is an innovative auto company operating in the world's largest auto market, but I'm still bearish on it.
Market At Risk Of Correcting In A 'Risk-Off' Reset? Stocks have been stuck in a compressing trading range for the past several months.
Enliven Therapeutics Chief Scientific Officer Sells ELVN 20K Shares Worth Over $500k The Chief Scientific Officer of this biopharmaceutical company sold 20,000 shares in mid-January 2026, amid the company's stock rising 71% throughout the month.
Protagonist Therapeutics Chief Medical Officer Sells PTGX 9,514 Shares for $784K to Cover Taxes The chief medical officer at one of the top pharmaceutical companies sold nearly 10,000 shares in late January 2026, but the reason was for something very simple.
1 Underrated Reason Netflix's Growth Story Isn't Over The streaming giant's stock is trading at much lower levels than it was a year ago.
Pete Buttigieg Says Trump 'Failed To Bring Down Prices,' Warns Affordability Crisis Is Hitting American Families Transportation Secretary Pete Buttigieg criticized Trump administration and Republicans for rising costs, stalled healthcare relief.
Amylyx Pharmaceuticals Co-Chief Executive Sells AMLX 138K Shares for $1.9 Million A Co-CEO of a leading neurotherapeutics developer reported significant insider selling amid a year of standout stock performance. But the sale is not what it seems.
4 Ways to Set Your 401(k) Up for Success in 2026 With the right strategy, you can grow your savings nicely this year.
Investment Firm Bouvel Raised Its Stake in This ETF by $8 Million. Is It a Buy? This actively managed fixed income ETF targets diversified bond exposure and reported a 5.09% annualized yield in its latest filing.
Harmony Biosciences' CFO Sells All of His Insider Shares, Worth $752,800 This bioscience company has had promising financials, yet one of its top executives exited his entire direct equity ownership in mid-January 2026.
Harmony Biosciences' CFO Sells All of Her Insider Shares, Worth $752,800 This bioscience company has had promising financials, yet one of its top executives exited her entire direct equity ownership in mid-January 2026.
2 Financial Stocks Poised for a Comeback in 2026 The sell-off in Mastercard and Visa is a tremendous buying opportunity for long-term investors.
2 High-Flying Electric Vehicle Stocks Have Serious Momentum -- But Are They Buys? These two EV stocks are hot topics in the automotive industry, but only one is a buy for risk-tolerant investors.
Arcellx Director Sells 6,000 Shares for $450,000 A director at one of the top clinical-stage biotech companies sold 6,000 insider shares towards the end of January 2026 amid the company's stock having an underwhelming performance in 2025.
Is This Fixed Income ETF a Buy After Symmetry Partners Initiated a Large Position Valued at Nearly $134 Million? The Dimensional Global Core Plus Fixed Income ETF offers access to global bonds spanning government, corporate, and securitized markets.
